Ximaract

Ximaract (Cefuroxime) is an antibiotic medication used intracamerally to prevent infections after eye surgery. It belongs to the cephalosporin class and is administered directly into the eye. Suitable for post-operative care in ophthalmic procedures.

Ximaract is primarily used intracamerally to reduce the risk of bacterial infections following cataract surgery or other intraocular procedures. It works by inhibiting bacterial cell wall synthesis, helping to protect the eye during recovery. This use is common in clinical settings to support patient outcomes after invasive eye treatments.

When administered intracamerally, Ximaract may help prevent infection by targeting susceptible bacteria. Patients may experience temporary clarity in the eye post-procedure as the medication takes effect. No immediate sensory effects are typically reported, as the application is localized to the surgical site.

Ximaract should only be handled and administered by healthcare professionals trained in intracameral techniques. Ensure the solution is clear and free of particles before use. Store at controlled room temperature and protect from light. Discard any unused portion after administration to maintain sterility.

As an intracameral antibiotic, Ximaract has minimal systemic exposure, reducing the risk of drug interactions. However, concurrent use of other ophthalmic medications should be evaluated for compatibility. Always inform healthcare providers about all medications being used to avoid potential conflicts.